Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.56 | N/A |
| PEG Ratio (TTM) | 1.71 | N/A |
| P/S Ratio (TTM) | 2.84 | N/A |
| P/B Ratio (TTM) | 2.81 | N/A |
| P/FCF Ratio (TTM) | 9.86 | N/A |
| Price to 5YR AVG Earnings Ratio | 24.96 | N/A |
| Price to 5YR AVG FCF Ratio | 19.56 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 13.91% | N/A |
| ROE (TTM) | 17.73% | N/A |
| Net Profit Margin (TTM) | 17.19% | N/A |
| ROIC 5YR AVG | 21.40% | N/A |
Growth (88%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 39.19% | 57.19% | 37.30% |
| Revenue | 8.55% | 15.02% | 9.17% |
| Net Income | 38.20% | 54.55% | 34.64% |
| Cash Flow | 323.73% | -1.06% | 38.64% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.34 | N/A |
| Quick Ratio (TTM) | 4.16 | N/A |
| D/E Ratio (TTM) | 0.01 | N/A |
| Interest Coverage (TTM) | 49.47 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 9.58 | N/A |
| LTL to 5YR AVG FCF | 0.49 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.01% | N/A |